166 related articles for article (PubMed ID: 20953643)
1. Subclinical myasthenia gravis causing increased sensitivity to botulinum toxin therapy.
Dressler D
J Neural Transm (Vienna); 2010 Nov; 117(11):1293-4. PubMed ID: 20953643
[TBL] [Abstract][Full Text] [Related]
2. Systemic effect of local and small-dose botulinum toxin injection to unmask subclinical myasthenia gravis.
Iwase T; Iwase C
Graefes Arch Clin Exp Ophthalmol; 2006 Mar; 244(3):415-6. PubMed ID: 16175373
[No Abstract] [Full Text] [Related]
3. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
[TBL] [Abstract][Full Text] [Related]
4. Treatment of cervical dystonia with botulinum toxin in a patient with myasthenia gravis.
Gonçalves MR; Barbosa ER; Zambon AA; Marchiori PE
Arq Neuropsiquiatr; 1999 Sep; 57(3A):683-5. PubMed ID: 10667297
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review.
Alboini PE; Damato V; Iorio R; Luigetti M; Evoli A
Neuromuscul Disord; 2015 Aug; 25(8):646-50. PubMed ID: 26028274
[TBL] [Abstract][Full Text] [Related]
6. Variable ptosis after botulinum toxin type a injection with positive ice test mimicking ocular myasthenia gravis.
Alaraj AM; Oystreck DT; Bosley TM
J Neuroophthalmol; 2013 Jun; 33(2):169-71. PubMed ID: 23681240
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis exacerbation with low dose ocular botulinum toxin for epiphoria.
Watts J; Brew B; Tisch S
J Clin Neurosci; 2015 Dec; 22(12):1979-81. PubMed ID: 26188667
[TBL] [Abstract][Full Text] [Related]
8. Is myasthenia gravis a contraindication for botulinum toxin?
Ma Q; Ran H; Ou C; Liu X; Lu Y; Huang H; Yang W; Yu L; Chen P; Huang X; Qiu L; Lin Z; Huang Z; Liu W
J Clin Neurosci; 2022 Jan; 95():44-47. PubMed ID: 34929650
[TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism and myasthenia gravis with features of Eaton-Lambert syndrome.
Mori M; Takamori M
Neurology; 1976 Sep; 26(9):882-7. PubMed ID: 181696
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis Lambert-Eaton overlap syndrome.
Oh SJ
Muscle Nerve; 2016 Jan; 53(1):20-6. PubMed ID: 26418033
[TBL] [Abstract][Full Text] [Related]
11. Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome.
Wirtz PW; Sotodeh M; Nijnuis M; Van Doorn PA; Van Engelen BG; Hintzen RQ; De Kort PL; Kuks JB; Twijnstra A; De Visser M; Visser LH; Wokke JH; Wintzen AR; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):766-8. PubMed ID: 12438488
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of myasthenia gravis and Lambert-Eaton syndrome.
Maselli RA
Neurol Clin; 1994 May; 12(2):285-303. PubMed ID: 8041343
[TBL] [Abstract][Full Text] [Related]
13. Overlap myasthenic syndrome: combined myasthenia gravis and Eaton-Lambert syndrome.
Oh SJ; Dwyer DS; Bradley RJ
Neurology; 1987 Aug; 37(8):1411-4. PubMed ID: 3614671
[TBL] [Abstract][Full Text] [Related]
14. [Intermittent myasthenic syndrome: combination of myasthenia gravis and myasthenic syndrome of the Lambert-Eaton type].
Sanadze AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):93-7. PubMed ID: 1664626
[TBL] [Abstract][Full Text] [Related]
15. Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia.
Fasano A; Bentivoglio AR; Ialongo T; Soleti F; Evoli A
Neurology; 2005 Jun; 64(12):2155-6. PubMed ID: 15985599
[No Abstract] [Full Text] [Related]
16. Myasthenic syndromes.
Farrugia ME
J R Coll Physicians Edinb; 2011 Mar; 41(1):43-7; quiz 48. PubMed ID: 21365067
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin for spasmodic torticollis in a patient with myasthenia gravis.
Emmerson J
Mov Disord; 1994 May; 9(3):367. PubMed ID: 8041381
[No Abstract] [Full Text] [Related]
18. Muscle paralysis produced by botulinum toxin type A injection in treated torticollis patients compared with toxin naive individuals.
Sloop RR; Cole D; Patel MC
Mov Disord; 2001 Jan; 16(1):100-5. PubMed ID: 11215566
[TBL] [Abstract][Full Text] [Related]
19. Update in the Management of Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
Bodkin C; Pascuzzi RM
Neurol Clin; 2021 Feb; 39(1):133-146. PubMed ID: 33223079
[TBL] [Abstract][Full Text] [Related]
20. Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?
Duarte GS; Rodrigues FB; Ferreira JJ; Costa J
Parkinsonism Relat Disord; 2018 Nov; 56():16-19. PubMed ID: 29910156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
